Triptorelin acetate and gonadorelin acetate (DrugBank: Gonadorelin, Triptorelin, Acetate)
2 diseases| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 49 | Systemic lupus erythematosus | 0 |
| 76 | Pituitary gonadotropin secretion hyperthyroidism | 1 |
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01278290 (ClinicalTrials.gov) | July 2010 | 14/1/2011 | Comparative Validation of the Triptorelin Test for the Diagnosis of CPP in Girls | Triptorelin Acetate Utilization for the Early Diagnosis of Central Precocious Puberty (CPP) in Girls. | Central Precocious Puberty;Sexual Precocity | Drug: Triptorelin acetate and Gonadorelin acetate;Drug: Gonadorelin acetate and Triptorelin acetate | Hospital de NiƱos R. Gutierrez de Buenos Aires | NULL | Active, not recruiting | 3 Years | 8 Years | Female | 40 | Phase 4 | Argentina |